- Q3 sales reached £424.7m, a 6.5% increase at constant currency.
- £25m cost savings targeted for 2025, with £100m annualized savings by 2027.
- Sales growth led by Beauty Actives, Fragrances & Flavours, and Crop Protection.
- US trade tariffs affected regional sales, notably in Asia and Latin America.
Sales Performance
In Q3 2025, Croda reported sales of £424.7 million, marking a 6.5% increase at constant currency compared to the previous year. Growth was primarily driven by Beauty Actives, Fragrances & Flavours, and Crop Protection, despite a challenging market environment.
Cost Savings and Efficiency
The company is on track to achieve £25 million in cost savings for 2025 and aims for £100 million in annualized savings by 2027. Efforts include optimizing production capacity and realigning costs through a multi-year operational efficiency program.
Market Outlook
Despite a challenging trading environment and low order book visibility, Croda maintains its full-year 2025 outlook, expecting to deliver £265 million to £295 million in adjusted profit before tax at constant currency. Q4 sales are anticipated to be seasonally lower as customers manage their year-end working capital.
Regional Impact
Sales performance varied by region, with EMEA, North America, and Latin America showing growth, while Asia experienced a decline. US trade tariffs contributed to regional volatility, particularly affecting pharma and industrial markets in Asia and agriculture markets in Latin America.
